Pharmafile Logo
Pharmafocus logo
Advanced Search

Alnylam cuts workforce by a third

January 23, 2012
Research and Development, Sales and Marketing Alnylam, Novartis, job cuts, rnai

Alnylam will cut 33% of its workforce this year as it looks to focus on developing its own products. The …

News

MPs to criticise NHS reforms

January 23, 2012
Sales and Marketing Clegg, Dorrell, NHS reform, health bill

Reform of the NHS is risking its financial stability and the care of the elderly, according to MPs. The concerns …

News

Carbogen Amcis buys French CRO

January 23, 2012
Manufacturing and Production Carbogen Amcis, Creapharm Parenterals

Swiss contract manufacturing organisation Carbogen Amcis has acquired a contract manufacturer based in France – Creapharm Parenterals – to bolster …

News

Contract research news in brief

January 23, 2012
Research and Development CoreLab Partners and Acurian, Quintiles, vivoPharma

Quintiles invests in new biomarket firm and sets up a new office in China, plus updates from vivoPharma, CoreLab Partners …

News
Vioxx image

Merck pays $37m to settle Canadian Vioxx claims

January 23, 2012
Sales and Marketing Canada, Merck, Vioxx

Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada.  The settlement …

News

Genzyme lifted by EU approval of Fabrazyme facility

January 20, 2012
Manufacturing and Production Boston, EMA, Fabrazyme, Genzyme

Sanofi subsidiary Genzyme moved a crucial step closer to resolving its long-standing manufacturing problems after the European Medicines Agency gave …

News

Payment changes of authority’s fees in France

January 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates, regulatory affairs

Changes are being made in the way fees are paid for regulatory submissions and procedures in France.  Fees are no …

News
Press release

Novartis’ Signifor recommended in Europe

January 20, 2012
Research and Development, Sales and Marketing CHMP, Cushing's disease, Novartis, Signifor

A European committee has recommended Novartis’ Signifor for the treatment of a rare, debilitating endocrine disorder. The European Committee for …

News
Gilenya image

EMA to review safety of MS drug Gilenya

January 20, 2012
Research and Development, Sales and Marketing CHMP, EMA, Novartis, gilenya

The European Medicines Agency has begun a review into the safety of Novartis’ multiple sclerosis drug Gilenya. This follows concerns …

News

British pharmacy to sell ‘smart pills’

January 20, 2012
Sales and Marketing Lloyds pharmacy, Proteus Biomedical, smart pill

Proteus Biomedical has teamed up with Lloydspharmacy to sell Helius, a smart pill that tells a patient when to take …

News

AZ and BMS diabetes drug needs more data

January 20, 2012
Research and Development, Sales and Marketing AstraZeneca, BMS, FDA approvals, diabetes

AstraZeneca and Bristol-Myers Squibb must supply more data on their diabetes treatment dapagliflozin, the FDA says.Currently being developed as monotherapy, …

News

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012
Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …

News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …

Appointment
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012
Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …

News
mike_crooks_web

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …

Appointment

Nurses come out against Health Bill

January 19, 2012
Sales and Marketing NHS, RCN, health bill, reforms

The union representing nurses and midwives in the UK has formally come out against the government’s health reform Bill.  The …

News
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012
Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …

News
Lucentis image

Lucentis approved in China

January 18, 2012
Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets

Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …

News

Lundbeck gets award for manufacturing excellence

January 18, 2012
Manufacturing and Production Lundbeck, Shingo, manufacturing

Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …

News

Former Bristol-Myers Squibb man becomes head of Savient Europe

January 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient

Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …

Appointment
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026